A class of enzymes that catalyzes the degradation of gelatin by acting on the peptide bonds. EC 3.4.24.-.
A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.
An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.
ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism.
A family of secreted protease inhibitory proteins that regulates the activity of SECRETED MATRIX METALLOENDOPEPTIDASES. They play an important role in modulating the proteolysis of EXTRACELLULAR MATRIX, most notably during tissue remodeling and inflammatory processes.
Enzymes that catalyze the degradation of collagen by acting on the peptide bonds.
A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a 21-kDa nonglycosylated protein found in tissue fluid and is secreted as a complex with progelatinase A by human fibroblast and uncomplexed from alveolar macrophages. An overexpression of TIMP-2 has been shown to inhibit invasive and metastatic activity of tumor cells and decrease tumor growth in vivo.
Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES.
A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a N-glycosylated protein, molecular weight 28 kD, produced by a vast range of cell types and found in a variety of tissues and body fluids. It has been shown to suppress metastasis and inhibit tumor invasion in vitro.
Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice.
A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components.
A phenyl mercury compound used mainly as a fungicide. Has also been used as a herbicide, slimicide, and bacteriocide.
Chemical reactions or functions, enzymatic activities, and metabolic pathways of living things.
The smallest member of the MATRIX METALLOPROTEINASES. It plays a role in tumor progression.
A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories.
An extracellular endopeptidase of vertebrate tissues similar to MATRIX METALLOPROTEINASE 1. It digests PROTEOGLYCAN; FIBRONECTIN; COLLAGEN types III, IV, V, and IX, and activates procollagenase. (Enzyme Nomenclature, 1992)
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).
A member of the MATRIX METALLOPROTEINASES that cleaves triple-helical COLLAGEN types I, II, and III.
A class of organic compounds containing a ring structure made up of more than one kind of atom, usually carbon plus another atom. The ring structure can be aromatic or nonaromatic.
A member of the family of tissue inhibitor of metalloproteinases. Mutations of the gene for TIMP3 PROTEIN causes Sorsby fundus dystrophy.
A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.
A method of gel filtration chromatography using agarose, the non-ionic component of agar, for the separation of compounds with molecular weights up to several million.
A water-soluble polypeptide (molecular weight approximately 8,000) extractable from the corpus luteum of pregnancy. It produces relaxation of the pubic symphysis and dilation of the uterine cervix in certain animal species. Its role in the human pregnant female is uncertain. (Dorland, 28th ed)
A secreted matrix metalloproteinase that plays a physiological role in the degradation of extracellular matrix found in skeletal tissues. It is synthesized as an inactive precursor that is activated by the proteolytic cleavage of its N-terminal propeptide.
Physiologically inactive substances that can be converted to active enzymes.
A member of the metalloproteinase family of enzymes that is principally responsible for cleaving FIBRILLAR COLLAGEN. It can degrade interstitial collagens, types I, II and III.
A metalloproteinase which degrades helical regions of native collagen to small fragments. Preferred cleavage is -Gly in the sequence -Pro-Xaa-Gly-Pro-. Six forms (or 2 classes) have been isolated from Clostridium histolyticum that are immunologically cross-reactive but possess different sequences and different specificities. Other variants have been isolated from Bacillus cereus, Empedobacter collagenolyticum, Pseudomonas marinoglutinosa, and species of Vibrio and Streptomyces. EC 3.4.24.3.
Matrix metalloproteinases that are associated with the CELL MEMBRANE, either through transmembrane domains or GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS. Membrane-type matrix metalloproteinases may act within the pericellular environment to influence the process of CELL MIGRATION.
Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.
A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.
A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).
Oral tissue surrounding and attached to TEETH.
'Elastin' is a highly elastic protein in connective tissue that allows many tissues in the body to resume their shape after stretching or contracting, such as the skin, lungs, and blood vessels.
The presence of organisms, or any foreign material that makes a drug preparation impure.
Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Culture media containing biologically active components obtained from previously cultured cells or tissues that have released into the media substances affecting certain cell functions (e.g., growth, lysis).
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest.
A darkly stained mat-like EXTRACELLULAR MATRIX (ECM) that separates cell layers, such as EPITHELIUM from ENDOTHELIUM or a layer of CONNECTIVE TISSUE. The ECM layer that supports an overlying EPITHELIUM or ENDOTHELIUM is called basal lamina. Basement membrane (BM) can be formed by the fusion of either two adjacent basal laminae or a basal lamina with an adjacent reticular lamina of connective tissue. BM, composed mainly of TYPE IV COLLAGEN; glycoprotein LAMININ; and PROTEOGLYCAN, provides barriers as well as channels between interacting cell layers.
Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).
Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.
The sum of the weight of all the atoms in a molecule.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Proteins prepared by recombinant DNA technology.
Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.

Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. (1/1060)

Three different membrane-type matrix metalloproteinases (MT1-, MT2-, and MT3-MMPs) are known to activate in vitro the zymogen of MMP-2 (pro-MMP-2, progelatinase A), which is one of the key MMPs in invasion and metastasis of various cancers. In the present study, we have examined production and activation of pro-MMP-2, expression of MT1-, MT2-, and MT3-MMPs and their correlation with pro-MMP-2 activation, and localization of MMP-2, MT1-MMP, and MT2-MMP in human astrocytic tumors. The sandwich enzyme immunoassay demonstrates that the production levels of pro-MMP-2 in the anaplastic astrocytomas and glioblastomas are significantly higher than that in the low-grade astrocytomas (P<0.05 and P<0.01, respectively), metastatic brain tumors (P<0.05), or normal brains (P<0.01). Gelatin zymography indicates that the pro-MMP-2 activation ratio is significantly higher in the glioblastomas than in other astrocytic tumors (P<0.01), metastatic brain tumors (P<0.01), and normal brains (P<0.01). The quantitative reverse transcription polymerase chain reaction analyses demonstrate that MT1-MMP and MT2-MMP are expressed predominantly in glioblastoma tissues (17/17 and 12/17 cases, respectively), and their expression levels increase significantly as tumor grade increases. MT3-MMP is detectable in both astrocytic tumor and normal brain tissues, but the mean expression level is approximately 50-fold lower compared with that of MT1-MMP and MT2-MMP in the glioblastomas. The activation ratio of pro-MMP-2 correlates directly with the expression levels of MT1-MMP and MT2-MMP but not MT3-MMP. In situ hybridization indicates that neoplastic astrocytes express MT1-MMP and MT2-MMP in the glioblastoma tissues (5/5 cases and 5/5 cases, respectively). Immunohistochemically, MT1-MMP and MT2-MMP are localized to the neoplastic astrocytes in glioblastoma samples (17/17 cases and 12/17 cases, respectively), which are also positive for MMP-2. In situ zymography shows gelatinolytic activity in the glioblastoma tissues but not in the normal brain tissues. These results suggest that both MT1-MMP and MT2-MMP play a key role in the activation of pro-MMP-2 in the human malignant astrocytic tumors and that the gelatinolytic activity is involved in the astrocytic tumor invasion.  (+info)

Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. (2/1060)

Collagenase-3 (MMP-13) is a human matrix metalloproteinase specifically expressed by invading tumor cells in squamous cell carcinomas (SCCs) of the head and neck. Here, we have further elucidated the role of MMP-13 in tumor invasion by examining its expression in invasive malignant tumors of the female genital tract. Using in situ hybridization, expression of MMP-13 mRNA was detected in 9 of 12 vulvar SCCs, primarily in tumor cells, but not in intact vulvar epithelium, in cervical SCCs (n = 12), or in endometrial (n = 11) or ovarian adenocarcinomas (n = 8). MMP-13 expression was especially abundant in vulvar carcinomas showing metastasis to lymph nodes and was associated with expression of membrane type 1 MMP by tumor cells and gelatinase-A (MMP-2) by stromal cells, as detected by immunohistochemistry. MMP-13 mRNAs were detected in 9 of 11 cell lines established from vulvar carcinomas and in 4 of 6 cell lines from cervical carcinomas, whereas endometrial (n = 10) and ovarian (n = 9) carcinoma cell lines were negative for MMP-13 mRNA. No correlation was detected between MMP-13 expression and p53 gene mutations in vulvar SCC cell lines. However, MMP-13 expression was detected in 5 of 6 vulvar and cervical SCC cell lines harboring HPV 16 or 68 DNA. These results show that MMP-13 is specifically expressed by malignantly transformed squamous epithelial cells, including vulvar SCC cells, and appears to serve as a marker for their invasive capacity.  (+info)

Injury-induced gelatinase and thrombin-like activities in regenerating and nonregenerating nervous systems. (3/1060)

It is now widely accepted that injured nerves, like any other injured tissue, need assistance from their extracellular milieu in order to heal. We compared the postinjury activities of thrombin and gelatinases, two types of proteolytic activities known to be critically involved in tissue healing, in nonregenerative (rat optic nerve) and regenerative (fish optic nerve and rat sciatic nerve) neural tissue. Unlike gelatinases, whose induction pattern was comparable in all three nerves, thrombin-like activity differed clearly between regenerating and nonregenerating nervous systems. Postinjury levels of this latter activity seem to dictate whether it will display beneficial or detrimental effects on the capacity of the tissue for repair. The results of this study further highlight the fact that tissue repair and nerve regeneration are closely linked and that substances that are not unique to the nervous system, but participate in wound healing in general, are also crucial for regeneration or its failure in the nervous system.  (+info)

Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. (4/1060)

PURPOSE: Retinal neovascularization is one of the leading causes of blindness. A crucial event in this process is the remodeling and penetration of the capillary basement membrane by migrating endothelial cells. This process requires proteolysis of basement membrane components by a variety of proteinases. The objective of the present study was to determine the expression of proteinases in human retinal tissues showing active neovascularization. METHODS: Epiretinal neovascular membranes surgically removed from patients with proliferative diabetic retinopathy were analyzed by zymography, and the types and amounts of proteinases present in the tissues were determined. Retinas from nondiabetic donor eyes served as control specimens. RESULTS: Both the high- (54 kDa) and low- (33 kDa) molecular-weight forms of urokinase were present at significantly higher levels in neovascular membranes than in normal retinas. The pro forms of the matrix metalloproteinases (MMP) MMP-2 and MMP-9 were significantly elevated in the neovascular membranes in comparison with levels in normal retinas. In addition, the active forms of these enzymes were present in the membranes, whereas there was no detectable level of the active forms in normal retinas. CONCLUSIONS: Human diabetic neovascular membranes contain high levels of urokinase and MMP. The increased activity of proteinases in the final common pathway of retinal neovascularization indicates that inhibition of these enzymes may be a useful therapeutic target as an alternative approach in the management of proliferative retinopathies.  (+info)

Leukemia inhibitory factor and oncostatin M stimulate collagenase-3 expression in osteoblasts. (5/1060)

Leukemia inhibitory factor (LIF) and oncostatin M (OSM) have multiple effects on skeletal remodeling. Although these cytokines modestly regulate collagen synthesis in osteoblasts, their effects on collagenase expression and collagen degradation are not known. We tested whether LIF and OSM regulate the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in osteoblast-enriched cells isolated from fetal rat calvariae. LIF and OSM increased collagenase-3 (MMP-13) mRNA and immunoreactive protein levels in a time- and dose-dependent manner. LIF and OSM enhanced the rate of transcription of the collagenase gene and stabilized collagenase mRNA in transcriptionally arrested cells. LIF and OSM failed to regulate the expression of gelatinase A (MMP-2) and B (MMP-9). LIF and OSM modestly stimulated the expression of TIMP-1 but did not alter the expression of TIMP-2 and -3. In conclusion, LIF and OSM stimulate collagenase-3 and TIMP-1 expression in osteoblasts, and these effects may be involved in mediating the bone remodeling actions of these cytokines.  (+info)

Luteinization and proteolysis in ovarian follicles of Meishan and Large White gilts during the preovulatory period. (6/1060)

This experiment was conducted to determine why follicles luteinize faster in the Meishan breed than in the Large White breed of pig. Follicles were recovered during the late follicular phase from ovaries of both breeds before and after administration of hCG given to mimic the LH surge. First, the patterns of cholesterol transporters (high and low density lipoproteins: HDL and LDL) were compared. Cholesterol transporters detected in follicular fluid consisted of HDL only. Similar amounts of Apolipoprotein A-I were found in all samples. There was no obvious breed effect on minor lipoproteins found in the HDL-rich fraction, and this pattern was altered similarly by hCG in the two breeds. The LDL-rich samples of serum from both breeds contained similar amounts of protein. Second, three steroidogenic enzymes, adrenodoxin, 17 alpha-hydroxylase-lyase (P450(17) alpha) and 3 beta-hydroxysteroid-dehydrogenase (3 beta-HSD) were detected by immunohistochemistry and quantified by image analysis on sections of the two largest follicles. Before hCG treatment, theca interna cells demonstrated immunoreactivities for adrenodoxin (strong), P450(17) alpha and 3 beta-HSD (very strong), whereas granulosa cells displayed immunoreactivities for adrenodoxin only. After hCG treatment, the localization of the enzymes was unchanged but the staining intensity of adrenodoxin on granulosa cells and 3 beta-HSD on theca cells increased (P < 0.01 and P < 0.05, respectively). Breed effects were detected for the amounts of adrenodoxin in theca cells (Meishan > Large White; P < 0.05) and of 17 alpha-hydroxylase (Large White > Meishan, P < 0.01). Breed x treatment interactions were never detected. Finally, gelatinases, plasminogen activator, plasminogen activator inhibitor, tissue inhibitors of metalloproteases (TIMP-1 and TIMP-2) were visualized by direct or reverse zymography or western blotting. Whatever the stage relative to LH administration, follicular fluid from Large White gilts contained more TIMP-1, and TIMP-2 (P < 0.02 and P < 0.01, respectively). No breed effect was detected for the amounts of gelatinases and plasminogen activator inhibitor 1. However, for these parameters, a significant breed x time interaction was obvious, as the Meishan follicles had a greater response to hCG (P < 0.01). Since proteolysis plays a key role in the bioavailability of growth factors such as insulin-like growth factor 1, fibroblast growth factor and transforming growth factor beta, which have the ability to alter gonadotrophin-induced progesterone production in pigs, the differences observed in its control in the present study may explain, at least in part, the different patterns of luteinization observed in Meishan and Large White follicles.  (+info)

Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. (7/1060)

A new member of the membrane-type matrix metalloproteinase (MT-MMP) subfamily tentatively named MT5-MMP was isolated from mouse brain cDNA library. It is predicted to contain (i) a candidate signal sequence, (ii) a propeptide region with the highly conserved PRCGVPD sequence, (iii) a potential furin recognition motif RRRRNKR, (iv) a zinc-binding catalytic domain, (v) a hemopexin-like domain, (vi) a 24-residue hydrophobic domain as a potential transmembrane domain, and (vii) a short cytosolic domain. Reverse transcriptase-polymerase chain reaction analysis of its transcripts indicates that MT5-MMP is expressed in a brain-specific manner consistent with the origin of its EST clone from cerebellum. It is also highly expressed during embryonic development at stages day 11 and 15. Like other MT-MMPs, MT5-MMP specifically activates progelatinase A when co-expressed in Madin-Darby canine kidney cells. Its ability to activate progelatinase A is dependent on its proteolytic activity since a mutation converting Glu to Ala in the zinc binding motif HE255LGH renders MT5-MMP inactive against progelatinase A. In contrast to other MT-MMPs, MT5-MMP tends to shed from cell surface as soluble proteinases, thus offering flexibility as both a cell bound and soluble proteinase for extracellular matrix remodeling processes. Taken together, these properties serve to distinguish MT5-MMP as a versatile MT-MMP playing an important role in extracellular matrix remodeling events in the brain and during embryonic development.  (+info)

Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation. (8/1060)

A large body of experimental evidence supports the participation of two groups of extracellular proteases, matrix metalloproteinases (MMPs), and plasminogen activators/plasmin, in tissue remodeling in physiological and pathological invasion. In the late mouse placenta, several tissue remodeling and cell invasion processes take place. Spongiotrophoblast migration into maternal decidua, as well as decidual extracellular matrix remodeling require the coordinated action of extracellular proteolytic enzymes. Via Northern and in situ hybridization, we have analyzed the spatio-temporal expression patterns of members of the MMP family (stromelysin-3, gelatinases A and B), as well as their inhibitors TIMP-1, -2 and -3 in late murine placenta (days 10.5 to 18.5 of gestation). Gelatinase activity in placental extracts was assessed by substrate zymography. Gelatinase A and stromelysin-3 were found to be prominently expressed in decidual tissue; shortly after midpregnancy, the decidual expression patterns of gelatinase A and stromelysin-3 became overlapping with each other, as well as with the expression domain of TIMP-2. On the other hand, gelatinase B transcripts were expressed only by trophoblast giant cells at day 10.5, and were downregulated at later stages. TIMP-1 and TIMP-3 transcripts were detected in decidual periphery at day 10.5, while later the expression was restricted to the endometrial stroma and spongiotrophoblasts, respectively. The areas of stromelysin-3 expression were the same (giant trophoblasts) or adjacent (decidua) to those where urokinase (uPA) transcripts were detected, suggesting a possible cooperation between these proteinases in placental remodeling. We generated mice doubly deficient for stromelysin-3 and uPA, and report here that these mice are viable and fertile. Furthermore, these animals do not manifest obvious placental abnormalities, thereby suggesting the existence of compensatory/redundant mechanisms involving other proteolytic enzymes. Our findings document the participation of MMPs and their inhibitors in the process of late murine placenta maturation, and warrant the characterization of other members of the MMP family, like membrane type-MMPs, in this process.  (+info)

Gelatinases are a group of matrix metalloproteinases (MMPs) that have the ability to degrade gelatin, which is denatured collagen. There are two main types of gelatinases: MMP-2 (gelatinase A) and MMP-9 (gelatinase B). These enzymes play important roles in various physiological processes such as tissue remodeling and wound healing, but they have also been implicated in several pathological conditions, including cancer, cardiovascular diseases, and neurological disorders.

MMP-2 is produced by a variety of cells, including fibroblasts, endothelial cells, and immune cells. It plays a crucial role in angiogenesis (the formation of new blood vessels) and tumor cell invasion and metastasis. MMP-9 is primarily produced by inflammatory cells such as neutrophils and macrophages, and it has been associated with the degradation of the extracellular matrix during inflammation and tissue injury.

Both MMP-2 and MMP-9 are synthesized as inactive zymogens and require activation by other proteases or physicochemical factors before they can exert their enzymatic activity. The regulation of gelatinase activity is tightly controlled at multiple levels, including gene expression, protein synthesis, secretion, activation, and inhibition. Dysregulation of gelatinase activity has been linked to various diseases, making them attractive targets for therapeutic intervention.

Matrix metalloproteinase 2 (MMP-2), also known as gelatinase A, is an enzyme that belongs to the matrix metalloproteinase family. MMPs are involved in the breakdown of extracellular matrix components, and MMP-2 is responsible for degrading type IV collagen, a major component of the basement membrane. This enzyme plays a crucial role in various physiological processes, including tissue remodeling, wound healing, and angiogenesis. However, its dysregulation has been implicated in several pathological conditions, such as cancer, arthritis, and cardiovascular diseases. MMP-2 is synthesized as an inactive proenzyme and requires activation by other proteases or chemical modifications before it can exert its proteolytic activity.

Medical Definition:

Matrix metalloproteinase 9 (MMP-9), also known as gelatinase B or 92 kDa type IV collagenase, is a member of the matrix metalloproteinase family. These enzymes are involved in degrading and remodeling the extracellular matrix (ECM) components, playing crucial roles in various physiological and pathological processes such as wound healing, tissue repair, and tumor metastasis.

MMP-9 is secreted as an inactive zymogen and activated upon removal of its propeptide domain. It can degrade several ECM proteins, including type IV collagen, elastin, fibronectin, and gelatin. MMP-9 has been implicated in numerous diseases, such as cancer, rheumatoid arthritis, neurological disorders, and cardiovascular diseases. Its expression is regulated at the transcriptional, translational, and post-translational levels, and its activity can be controlled by endogenous inhibitors called tissue inhibitors of metalloproteinases (TIMPs).

Metalloendopeptidases are a type of enzymes that cleave peptide bonds in proteins, specifically at interior positions within the polypeptide chain. They require metal ions as cofactors for their catalytic activity, typically zinc (Zn2+) or cobalt (Co2+). These enzymes play important roles in various biological processes such as protein degradation, processing, and signaling. Examples of metalloendopeptidases include thermolysin, matrix metalloproteinases (MMPs), and neutrophil elastase.

A Tissue Inhibitor of Metalloproteinases (TIMPs) is a group of four naturally occurring proteins that play a crucial role in the regulation of extracellular matrix (ECM) remodeling. They function by inhibiting Matrix Metalloproteinases (MMPs), which are a family of enzymes responsible for degrading various components of the ECM, such as collagen and elastin.

By controlling MMP activity, TIMPs help maintain the balance between ECM synthesis and degradation, thereby ensuring proper tissue structure and function. An imbalance in TIMPs and MMPs has been implicated in various pathological conditions, including fibrosis, cancer, and inflammatory diseases.

There are four known TIMPs: TIMP1, TIMP2, TIMP3, and TIMP4, each with distinct expression patterns and substrate specificities. They not only inhibit MMPs but also have other functions, such as promoting cell survival, modulating cell growth and differentiation, and regulating angiogenesis.

Collagenases are a group of enzymes that have the ability to break down collagen, which is a structural protein found in connective tissues such as tendons, ligaments, and skin. Collagen is an important component of the extracellular matrix, providing strength and support to tissues throughout the body.

Collagenases are produced by various organisms, including bacteria, animals, and humans. In humans, collagenases play a crucial role in normal tissue remodeling and repair processes, such as wound healing and bone resorption. However, excessive or uncontrolled activity of collagenases can contribute to the development of various diseases, including arthritis, periodontitis, and cancer metastasis.

Bacterial collagenases are often used in research and medical applications for their ability to digest collagen quickly and efficiently. For example, they may be used to study the structure and function of collagen or to isolate cells from tissues. However, the clinical use of bacterial collagenases is limited due to concerns about their potential to cause tissue damage and inflammation.

Overall, collagenases are important enzymes that play a critical role in maintaining the health and integrity of connective tissues throughout the body.

Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) is a protein that inhibits the activity of matrix metalloproteinases (MMPs), which are enzymes involved in breaking down and remodeling extracellular matrix (ECM) components. TIMP-2 specifically inhibits MMP-2, also known as gelatinase A, by forming a 1:1 complex with it.

TIMP-2 is produced by various cell types, including fibroblasts, endothelial cells, and smooth muscle cells. It plays important roles in regulating ECM turnover, tissue remodeling, and wound healing. Imbalances between MMPs and TIMPs have been implicated in several pathological conditions, such as cancer, fibrosis, and cardiovascular diseases.

In the context of cancer, increased MMP-2 activity has been associated with tumor invasion and metastasis. TIMP-2 can counteract this effect by inhibiting MMP-2, thus potentially reducing tumor progression. However, the precise role of TIMP-2 in cancer is complex and may depend on various factors, including the type of cancer and the stage of disease progression.

Matrix metalloproteinase inhibitors (MMPIs) are a class of pharmaceutical compounds that work by inhibiting the activity of matrix metalloproteinases (MMPs), which are a family of enzymes involved in the breakdown and remodeling of extracellular matrix (ECM) proteins. MMPs play important roles in various physiological processes, including tissue repair, wound healing, and angiogenesis, but they can also contribute to the pathogenesis of several diseases, such as cancer, arthritis, and cardiovascular disease.

MMPIs are designed to block the activity of MMPs by binding to their active site or zinc-binding domain, thereby preventing them from degrading ECM proteins. These inhibitors can be broad-spectrum, targeting multiple MMPs, or selective, targeting specific MMP isoforms.

MMPIs have been studied as potential therapeutic agents for various diseases, including cancer, where they have shown promise in reducing tumor growth, invasion, and metastasis by inhibiting the activity of MMPs that promote these processes. However, clinical trials with MMPIs have yielded mixed results, and some studies have suggested that broad-spectrum MMPIs may have off-target effects that can lead to adverse side effects. Therefore, there is ongoing research into developing more selective MMPIs that target specific MMP isoforms involved in disease pathogenesis while minimizing off-target effects.

Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) is a protein that inhibits the activity of matrix metalloproteinases (MMPs), which are enzymes responsible for breaking down extracellular matrix proteins. TIMP-1 plays a crucial role in regulating the balance between the synthesis and degradation of the extracellular matrix, thereby maintaining tissue homeostasis. It is involved in various biological processes, including cell growth, differentiation, and apoptosis (programmed cell death). An imbalance between MMPs and TIMPs has been implicated in several pathological conditions, such as cancer, fibrosis, and inflammatory diseases.

Pepsin A is defined as a digestive enzyme that is primarily secreted by the chief cells in the stomach's fundic glands. It plays a crucial role in protein catabolism, helping to break down food proteins into smaller peptides during the digestive process. Pepsin A has an optimal pH range of 1.5-2.5 for its enzymatic activity and is activated from its inactive precursor, pepsinogen, upon exposure to acidic conditions in the stomach.

Matrix metalloproteinases (MMPs) are a group of enzymes responsible for the degradation and remodeling of the extracellular matrix, the structural framework of most tissues in the body. These enzymes play crucial roles in various physiological processes such as tissue repair, wound healing, and embryonic development. They also participate in pathological conditions like tumor invasion, metastasis, and inflammatory diseases by breaking down the components of the extracellular matrix, including collagens, elastins, proteoglycans, and gelatins. MMPs are zinc-dependent endopeptidases that require activation from their proenzyme form to become fully functional. Their activity is tightly regulated at various levels, including gene expression, protein synthesis, and enzyme inhibition by tissue inhibitors of metalloproteinases (TIMPs). Dysregulation of MMPs has been implicated in several diseases, making them potential therapeutic targets for various clinical interventions.

Phenylmercuric Acetate is not typically defined in a medical context, but it is a chemical compound with the formula C7H8HgO2. It is an organomercury compound that has been used as a fungicide and preservative in various industrial and medical applications. However, due to its potential toxicity, especially its ability to cause neurological damage, its use has been largely discontinued.

Biochemical processes refer to the chemical reactions and transformations that occur within living organisms to maintain life. These processes are mediated by biological macromolecules such as enzymes, nucleic acids, and proteins, and are essential for various functions including metabolism, growth, reproduction, and response to environmental stimuli.

Examples of biochemical processes include:

1. Metabolic pathways: These are series of chemical reactions that convert nutrients into energy or building blocks for cellular components. Examples include glycolysis, citric acid cycle, and beta-oxidation.
2. Signal transduction: This is the process by which cells respond to external signals such as hormones and neurotransmitters. It involves a series of biochemical reactions that transmit the signal from the cell surface to the nucleus, leading to changes in gene expression.
3. Protein synthesis: This is the process by which genetic information encoded in DNA and RNA is translated into functional proteins. It involves several biochemical steps including transcription, translation, and post-translational modifications.
4. Cell division: This is the process by which cells replicate and divide to form new cells. It involves a series of biochemical reactions that regulate the cell cycle, DNA replication, and cytokinesis.
5. Apoptosis: This is the programmed cell death that occurs in multicellular organisms as a means of eliminating damaged or unnecessary cells. It involves a series of biochemical reactions that activate caspases, which are proteases that degrade cellular components.

Matrix metalloproteinase 7 (MMP-7), also known as matrilysin, is a type of enzyme that belongs to the matrix metalloproteinase family. These enzymes are capable of degrading various components of the extracellular matrix, which is the structural framework of tissues in the body. MMP-7 has a broad range of substrates and can break down proteins such as collagens, gelatins, and caseins, as well as other matrix proteins. It plays important roles in tissue remodeling, wound healing, and cell migration, among other processes.

MMP-7 is synthesized and secreted by various cells, including epithelial cells, fibroblasts, and immune cells. It is a small enzyme with a molecular weight of around 28 kDa and is secreted in an active form, unlike many other MMPs that are secreted as inactive proenzymes and require activation by other proteases.

Increased expression of MMP-7 has been implicated in several pathological conditions, including cancer, where it can contribute to tumor invasion and metastasis by degrading the extracellular matrix and releasing growth factors. It has also been associated with inflammatory diseases such as rheumatoid arthritis and periodontitis.

Gelatin is not strictly a medical term, but it is often used in medical contexts. Medically, gelatin is recognized as a protein-rich substance that is derived from collagen, which is found in the skin, bones, and connective tissue of animals. It is commonly used in the production of various medical and pharmaceutical products such as capsules, wound dressings, and drug delivery systems due to its biocompatibility and ability to form gels.

In a broader sense, gelatin is a translucent, colorless, flavorless food ingredient that is derived from collagen through a process called hydrolysis. It is widely used in the food industry as a gelling agent, thickener, stabilizer, and texturizer in various foods such as candies, desserts, marshmallows, and yogurts.

It's worth noting that while gelatin has many uses, it may not be suitable for vegetarians or those with dietary restrictions since it is derived from animal products.

Matrix metalloproteinase 3 (MMP-3), also known as stromelysin-1, is a member of the matrix metalloproteinase family. These are a group of enzymes involved in the degradation of the extracellular matrix, the network of proteins and other molecules that provides structural and biochemical support to surrounding cells. MMP-3 is secreted by various cell types, including fibroblasts, synovial cells, and chondrocytes, in response to inflammatory cytokines.

MMP-3 has the ability to degrade several extracellular matrix components, such as proteoglycans, laminin, fibronectin, and various types of collagen. It also plays a role in processing and activating other MMPs, thereby contributing to the overall breakdown of the extracellular matrix. This activity is crucial during processes like tissue remodeling, wound healing, and embryonic development; however, uncontrolled or excessive MMP-3 activation can lead to pathological conditions, including arthritis, cancer, and cardiovascular diseases.

In summary, Matrix metalloproteinase 3 (MMP-3) is a proteolytic enzyme involved in the degradation of the extracellular matrix and the activation of other MMPs. Its dysregulation has been implicated in several diseases.

Protease inhibitors are a class of antiviral drugs that are used to treat infections caused by retroviruses, such as the human immunodeficiency virus (HIV), which is responsible for causing AIDS. These drugs work by blocking the activity of protease enzymes, which are necessary for the replication and multiplication of the virus within infected cells.

Protease enzymes play a crucial role in the life cycle of retroviruses by cleaving viral polyproteins into functional units that are required for the assembly of new viral particles. By inhibiting the activity of these enzymes, protease inhibitors prevent the virus from replicating and spreading to other cells, thereby slowing down the progression of the infection.

Protease inhibitors are often used in combination with other antiretroviral drugs as part of highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS. Common examples of protease inhibitors include saquinavir, ritonavir, indinavir, and atazanavir. While these drugs have been successful in improving the outcomes of people living with HIV/AIDS, they can also cause side effects such as nausea, diarrhea, headaches, and lipodystrophy (changes in body fat distribution).

Matrix Metalloproteinase 8 (MMP-8), also known as Collagenase-2 or Neutrophil Collagenase, is an enzyme that belongs to the Matrix Metalloproteinases family. MMP-8 is primarily produced by neutrophils and has the ability to degrade various components of the extracellular matrix (ECM), including collagens, gelatin, and elastin. It plays a crucial role in tissue remodeling, wound healing, and inflammatory responses. MMP-8 is also involved in the pathogenesis of several diseases, such as periodontitis, rheumatoid arthritis, and cancer, where it contributes to the breakdown of the ECM and promotes tissue destruction and invasion.

Heterocyclic compounds are organic molecules that contain a ring structure made up of at least one atom that is not carbon, known as a heteroatom. These heteroatoms can include nitrogen, oxygen, sulfur, or other elements. In the case of "1-ring" heterocyclic compounds, the molecule contains a single ring structure composed of these heteroatoms and carbon atoms. Examples of 1-ring heterocyclic compounds include pyridine (contains one nitrogen atom in the ring), furan (contains one oxygen atom in the ring), and thiophene (contains one sulfur atom in the ring). These compounds play important roles in various biological processes and are also found in many drugs, dyes, and materials.

Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) is a member of the tissue inhibitors of metalloproteinases (TIMPs) family, which are natural inhibitors of matrix metalloproteinases (MMPs), a group of enzymes involved in the degradation and remodeling of extracellular matrix components.

TIMP-3 is unique among TIMPs because it can inhibit all known MMPs and also has the ability to inhibit some members of the ADAM (a disintegrin and metalloproteinase) family, which are involved in protein ectodomain shedding and cell adhesion.

TIMP-3 is a secreted glycoprotein that binds to the extracellular matrix and regulates MMP activity locally. It has been shown to play important roles in various biological processes, including tissue remodeling, angiogenesis, inflammation, and apoptosis. Dysregulation of TIMP-3 expression or function has been implicated in several diseases, such as cancer, fibrosis, and neurodegenerative disorders.

The extracellular matrix (ECM) is a complex network of biomolecules that provides structural and biochemical support to cells in tissues and organs. It is composed of various proteins, glycoproteins, and polysaccharides, such as collagens, elastin, fibronectin, laminin, and proteoglycans. The ECM plays crucial roles in maintaining tissue architecture, regulating cell behavior, and facilitating communication between cells. It provides a scaffold for cell attachment, migration, and differentiation, and helps to maintain the structural integrity of tissues by resisting mechanical stresses. Additionally, the ECM contains various growth factors, cytokines, and chemokines that can influence cellular processes such as proliferation, survival, and differentiation. Overall, the extracellular matrix is essential for the normal functioning of tissues and organs, and its dysregulation can contribute to various pathological conditions, including fibrosis, cancer, and degenerative diseases.

Chromatography, agarose is a type of chromatography technique that utilizes agarose gel as the stationary phase in the separation and analysis of biological molecules, such as DNA, RNA, and proteins. This method is commonly used in molecular biology for various applications, including DNA fragment separation, protein purification, and detection of specific nucleic acid sequences or proteins.

Agarose gel is a matrix made from agarose, a polysaccharide derived from seaweed. It has a porous structure with uniform pore size that allows for the size-based separation of molecules based on their ability to migrate through the gel under an electric field (in the case of electrophoresis) or by capillary action (in the case of capillary electrophoresis).

The charged molecules, such as DNA or proteins, interact with the agarose matrix and move through the gel at different rates depending on their size, charge, and shape. Smaller molecules can migrate more quickly through the pores of the gel, while larger molecules are retarded due to their inability to easily pass through the pores. This results in a separation of the molecules based on their physical properties, allowing for their analysis and characterization.

In summary, chromatography, agarose refers to the use of agarose gel as the stationary phase in the separation and analysis of biological molecules using various chromatography techniques, such as electrophoresis or capillary electrophoresis.

Relaxin is a hormone produced by the ovaries and, during pregnancy, also by the placenta and the fetal membranes. Its primary function is to relax the uterus and pelvic joints in preparation for childbirth, hence its name. It does this by softening the connective tissues and increasing their elasticity, which allows them to stretch more easily. Relaxin also plays a role in the cardiovascular system during pregnancy, helping to maintain healthy blood pressure levels.

Additionally, relaxin has been shown to have effects on other parts of the body, such as reducing muscle stiffness and joint pain, increasing flexibility, and potentially even playing a role in bone metabolism. However, more research is needed to fully understand all of its functions and potential therapeutic uses.

Medical Definition:

Matrix Metalloproteinase 13 (MMP-13), also known as collagenase 3, is an enzyme belonging to the family of Matrix Metalloproteinases. These enzymes are involved in the degradation of extracellular matrix components, playing crucial roles in various physiological and pathological processes such as tissue remodeling, wound healing, and cancer progression.

MMP-13 has a specific affinity for cleaving type II collagen, one of the major structural proteins found in articular cartilage. It is also capable of degrading other extracellular matrix components like proteoglycans, elastin, and gelatin. This enzyme is primarily produced by chondrocytes, synovial fibroblasts, and osteoblasts.

Increased expression and activity of MMP-13 have been implicated in the pathogenesis of several diseases, most notably osteoarthritis (OA) and cancer. In OA, overexpression of MMP-13 leads to excessive degradation of articular cartilage, contributing to joint damage and degeneration. In cancer, MMP-13 facilitates tumor cell invasion and metastasis by breaking down the surrounding extracellular matrix.

Regulation of MMP-13 activity is essential for maintaining tissue homeostasis and preventing disease progression. Various therapeutic strategies aiming to inhibit MMP-13 activity are being explored as potential treatments for osteoarthritis and cancer.

Enzyme precursors are typically referred to as zymogens or proenzymes. These are inactive forms of enzymes that can be activated under specific conditions. When the need for the enzyme's function arises, the proenzyme is converted into its active form through a process called proteolysis, where it is cleaved by another enzyme. This mechanism helps control and regulate the activation of certain enzymes in the body, preventing unwanted or premature reactions. A well-known example of an enzyme precursor is trypsinogen, which is converted into its active form, trypsin, in the digestive system.

Medical Definition of Matrix Metalloproteinase 1 (MMP-1):

Matrix metalloproteinase 1, also known as collagenase-1 or fibroblast collagenase, is a member of the matrix metalloproteinase family of enzymes. These enzymes are involved in degrading and remodeling extracellular matrix components, such as collagens, gelatins, and other proteins. MMP-1 specifically targets interstitial collagens (types I, II, III, VII, and X) and plays a crucial role in tissue repair, wound healing, and pathological processes like tumor invasion and metastasis. It is secreted as an inactive proenzyme and requires activation before it can carry out its proteolytic functions. MMP-1 activity is regulated at various levels, including transcription, activation, and inhibition by endogenous tissue inhibitors of metalloproteinases (TIMPs). Dysregulation of MMP-1 has been implicated in several diseases, such as arthritis, cancer, and fibrosis.

Microbial collagenase is not a medical term per se, but it does refer to an enzyme that is used in various medical and research contexts. Collagenases are a group of enzymes that break down collagen, a structural protein found in connective tissues such as skin, tendons, and ligaments. Microbial collagenase is a type of collagenase that is produced by certain bacteria, such as Clostridium histolyticum.

In medical terms, microbial collagenase is used in various therapeutic and research applications, including:

1. Wound healing: Microbial collagenase can be used to break down and remove necrotic tissue from wounds, which can help promote healing and prevent infection.
2. Dental applications: Collagenases have been used in periodontal therapy to remove calculus and improve the effectiveness of root planing and scaling procedures.
3. Research: Microbial collagenase is a valuable tool for researchers studying the structure and function of collagen and other extracellular matrix proteins. It can be used to digest tissue samples, allowing scientists to study the individual components of the extracellular matrix.

It's important to note that while microbial collagenase has many useful applications, it must be used with care, as excessive or improper use can damage healthy tissues and cause adverse effects.

Matrix metalloproteinases (MMPs) are a group of enzymes that can degrade various components of the extracellular matrix (ECM). Membrane-associated matrix metalloproteinases (MT-MMPs) are a subgroup of MMPs that are bound to the cell membrane through a transmembrane domain. They play important roles in ECM remodeling, tissue repair and regeneration, as well as in various pathological processes such as cancer invasion and metastasis.

MT-MMPs can activate other MMPs and convert pro-MMPs into their active forms. They also have the ability to cleave cell surface receptors, adhesion molecules, and growth factors, thereby regulating various cellular processes such as cell migration, proliferation, and apoptosis.

The membrane-associated matrix metalloproteinases include MMP-14 (MT1-MMP), MMP-15 (MT2-MMP), MMP-16 (MT3-MMP), MMP-17 (MT4-MMP), and MMP-24 (MT5-MMP). Dysregulation of MT-MMPs has been implicated in various diseases, including cancer, fibrosis, and neurodegenerative disorders.

Electrophoresis, polyacrylamide gel (EPG) is a laboratory technique used to separate and analyze complex mixtures of proteins or nucleic acids (DNA or RNA) based on their size and electrical charge. This technique utilizes a matrix made of cross-linked polyacrylamide, a type of gel, which provides a stable and uniform environment for the separation of molecules.

In this process:

1. The polyacrylamide gel is prepared by mixing acrylamide monomers with a cross-linking agent (bis-acrylamide) and a catalyst (ammonium persulfate) in the presence of a buffer solution.
2. The gel is then poured into a mold and allowed to polymerize, forming a solid matrix with uniform pore sizes that depend on the concentration of acrylamide used. Higher concentrations result in smaller pores, providing better resolution for separating smaller molecules.
3. Once the gel has set, it is placed in an electrophoresis apparatus containing a buffer solution. Samples containing the mixture of proteins or nucleic acids are loaded into wells on the top of the gel.
4. An electric field is applied across the gel, causing the negatively charged molecules to migrate towards the positive electrode (anode) while positively charged molecules move toward the negative electrode (cathode). The rate of migration depends on the size, charge, and shape of the molecules.
5. Smaller molecules move faster through the gel matrix and will migrate farther from the origin compared to larger molecules, resulting in separation based on size. Proteins and nucleic acids can be selectively stained after electrophoresis to visualize the separated bands.

EPG is widely used in various research fields, including molecular biology, genetics, proteomics, and forensic science, for applications such as protein characterization, DNA fragment analysis, cloning, mutation detection, and quality control of nucleic acid or protein samples.

Substrate specificity in the context of medical biochemistry and enzymology refers to the ability of an enzyme to selectively bind and catalyze a chemical reaction with a particular substrate (or a group of similar substrates) while discriminating against other molecules that are not substrates. This specificity arises from the three-dimensional structure of the enzyme, which has evolved to match the shape, charge distribution, and functional groups of its physiological substrate(s).

Substrate specificity is a fundamental property of enzymes that enables them to carry out highly selective chemical transformations in the complex cellular environment. The active site of an enzyme, where the catalysis takes place, has a unique conformation that complements the shape and charge distribution of its substrate(s). This ensures efficient recognition, binding, and conversion of the substrate into the desired product while minimizing unwanted side reactions with other molecules.

Substrate specificity can be categorized as:

1. Absolute specificity: An enzyme that can only act on a single substrate or a very narrow group of structurally related substrates, showing no activity towards any other molecule.
2. Group specificity: An enzyme that prefers to act on a particular functional group or class of compounds but can still accommodate minor structural variations within the substrate.
3. Broad or promiscuous specificity: An enzyme that can act on a wide range of structurally diverse substrates, albeit with varying catalytic efficiencies.

Understanding substrate specificity is crucial for elucidating enzymatic mechanisms, designing drugs that target specific enzymes or pathways, and developing biotechnological applications that rely on the controlled manipulation of enzyme activities.

Exudates and transudates are two types of bodily fluids that can accumulate in various body cavities or tissues as a result of injury, inflammation, or other medical conditions. Here are the medical definitions:

1. Exudates: These are fluids that accumulate due to an active inflammatory process. Exudates contain high levels of protein, white blood cells (such as neutrophils and macrophages), and sometimes other cells like red blood cells or cellular debris. They can be yellow, green, or brown in color and may have a foul odor due to the presence of dead cells and bacteria. Exudates are often seen in conditions such as abscesses, pneumonia, pleurisy, or wound infections.

Examples of exudative fluids include pus, purulent discharge, or inflammatory effusions.

2. Transudates: These are fluids that accumulate due to increased hydrostatic pressure or decreased oncotic pressure within the blood vessels. Transudates contain low levels of protein and cells compared to exudates. They are typically clear and pale yellow in color, with no odor. Transudates can be found in conditions such as congestive heart failure, liver cirrhosis, or nephrotic syndrome.

Examples of transudative fluids include ascites, pleural effusions, or pericardial effusions.

It is essential to differentiate between exudates and transudates because their underlying causes and treatment approaches may differ significantly. Medical professionals often use various tests, such as fluid analysis, to determine whether a fluid sample is an exudate or transudate.

Collagen is the most abundant protein in the human body, and it is a major component of connective tissues such as tendons, ligaments, skin, and bones. Collagen provides structure and strength to these tissues and helps them to withstand stretching and tension. It is made up of long chains of amino acids, primarily glycine, proline, and hydroxyproline, which are arranged in a triple helix structure. There are at least 16 different types of collagen found in the body, each with slightly different structures and functions. Collagen is important for maintaining the integrity and health of tissues throughout the body, and it has been studied for its potential therapeutic uses in various medical conditions.

Gingiva is the medical term for the soft tissue that surrounds the teeth and forms the margin of the dental groove, also known as the gum. It extends from the mucogingival junction to the base of the cervical third of the tooth root. The gingiva plays a crucial role in protecting and supporting the teeth and maintaining oral health by providing a barrier against microbial invasion and mechanical injury.

Elastin is a protein that provides elasticity to tissues and organs, allowing them to resume their shape after stretching or contracting. It is a major component of the extracellular matrix in many tissues, including the skin, lungs, blood vessels, and ligaments. Elastin fibers can stretch up to 1.5 times their original length and then return to their original shape due to the unique properties of this protein. The elastin molecule is made up of cross-linked chains of the protein tropoelastin, which are produced by cells called fibroblasts and then assembled into larger elastin fibers by enzymes called lysyl oxidases. Elastin has a very long half-life, with some estimates suggesting that it can remain in the body for up to 70 years or more.

Drug contamination refers to the presence of impurities or foreign substances in a pharmaceutical drug or medication. These impurities can include things like bacteria, chemicals, or other drugs that are not intended to be present in the final product. Drug contamination can occur at any stage during the production, storage, or distribution of a medication and can potentially lead to reduced effectiveness, increased side effects, or serious health risks for patients. It is closely monitored and regulated by various health authorities to ensure the safety and efficacy of medications.

Fibronectin is a high molecular weight glycoprotein that is found in many tissues and body fluids, including plasma, connective tissue, and the extracellular matrix. It is composed of two similar subunits that are held together by disulfide bonds. Fibronectin plays an important role in cell adhesion, migration, and differentiation by binding to various cell surface receptors, such as integrins, and other extracellular matrix components, such as collagen and heparan sulfate proteoglycans.

Fibronectin has several isoforms that are produced by alternative splicing of a single gene transcript. These isoforms differ in their biological activities and can be found in different tissues and developmental stages. Fibronectin is involved in various physiological processes, such as wound healing, tissue repair, and embryonic development, and has been implicated in several pathological conditions, including fibrosis, tumor metastasis, and thrombosis.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Conditioned culture media refers to a type of growth medium that has been previously used to culture and maintain the cells of an organism. The conditioned media contains factors secreted by those cells, such as hormones, nutrients, and signaling molecules, which can affect the behavior and growth of other cells that are introduced into the media later on.

When the conditioned media is used for culturing a new set of cells, it can provide a more physiologically relevant environment than traditional culture media, as it contains factors that are specific to the original cell type. This can be particularly useful in studies that aim to understand cell-cell interactions and communication, or to mimic the natural microenvironment of cells in the body.

It's important to note that conditioned media should be handled carefully and used promptly after preparation, as the factors it contains can degrade over time and affect the quality of the results.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

I'm sorry for any confusion, but "horses" is not a medical term. It is the common name given to the species *Equus ferus caballus*, which are large domesticated mammals used for transportation, work, and recreation. If you have any questions about horses or a related topic that you would like a medical perspective on, please let me know and I'd be happy to help!

The basement membrane is a thin, specialized layer of extracellular matrix that provides structural support and separates epithelial cells (which line the outer surfaces of organs and blood vessels) from connective tissue. It is composed of two main layers: the basal lamina, which is produced by the epithelial cells, and the reticular lamina, which is produced by the connective tissue. The basement membrane plays important roles in cell adhesion, migration, differentiation, and survival.

The basal lamina is composed mainly of type IV collagen, laminins, nidogens, and proteoglycans, while the reticular lamina contains type III collagen, fibronectin, and other matrix proteins. The basement membrane also contains a variety of growth factors and cytokines that can influence cell behavior.

Defects in the composition or organization of the basement membrane can lead to various diseases, including kidney disease, eye disease, and skin blistering disorders.

Extracellular matrix (ECM) proteins are a group of structural and functional molecules that provide support, organization, and regulation to the cells in tissues and organs. The ECM is composed of a complex network of proteins, glycoproteins, and carbohydrates that are secreted by the cells and deposited outside of them.

ECM proteins can be classified into several categories based on their structure and function, including:

1. Collagens: These are the most abundant ECM proteins and provide strength and stability to tissues. They form fibrils that can withstand high tensile forces.
2. Proteoglycans: These are complex molecules made up of a core protein and one or more glycosaminoglycan (GAG) chains. The GAG chains attract water, making proteoglycans important for maintaining tissue hydration and resilience.
3. Elastin: This is an elastic protein that allows tissues to stretch and recoil, such as in the lungs and blood vessels.
4. Fibronectins: These are large glycoproteins that bind to cells and ECM components, providing adhesion, migration, and signaling functions.
5. Laminins: These are large proteins found in basement membranes, which provide structural support for epithelial and endothelial cells.
6. Tenascins: These are large glycoproteins that modulate cell adhesion and migration, and regulate ECM assembly and remodeling.

Together, these ECM proteins create a microenvironment that influences cell behavior, differentiation, and function. Dysregulation of ECM proteins has been implicated in various diseases, including fibrosis, cancer, and degenerative disorders.

Fibroblasts are specialized cells that play a critical role in the body's immune response and wound healing process. They are responsible for producing and maintaining the extracellular matrix (ECM), which is the non-cellular component present within all tissues and organs, providing structural support and biochemical signals for surrounding cells.

Fibroblasts produce various ECM proteins such as collagens, elastin, fibronectin, and laminins, forming a complex network of fibers that give tissues their strength and flexibility. They also help in the regulation of tissue homeostasis by controlling the turnover of ECM components through the process of remodeling.

In response to injury or infection, fibroblasts become activated and start to proliferate rapidly, migrating towards the site of damage. Here, they participate in the inflammatory response, releasing cytokines and chemokines that attract immune cells to the area. Additionally, they deposit new ECM components to help repair the damaged tissue and restore its functionality.

Dysregulation of fibroblast activity has been implicated in several pathological conditions, including fibrosis (excessive scarring), cancer (where they can contribute to tumor growth and progression), and autoimmune diseases (such as rheumatoid arthritis).

Molecular weight, also known as molecular mass, is the mass of a molecule. It is expressed in units of atomic mass units (amu) or daltons (Da). Molecular weight is calculated by adding up the atomic weights of each atom in a molecule. It is a useful property in chemistry and biology, as it can be used to determine the concentration of a substance in a solution, or to calculate the amount of a substance that will react with another in a chemical reaction.

Western blotting is a laboratory technique used in molecular biology to detect and quantify specific proteins in a mixture of many different proteins. This technique is commonly used to confirm the expression of a protein of interest, determine its size, and investigate its post-translational modifications. The name "Western" blotting distinguishes this technique from Southern blotting (for DNA) and Northern blotting (for RNA).

The Western blotting procedure involves several steps:

1. Protein extraction: The sample containing the proteins of interest is first extracted, often by breaking open cells or tissues and using a buffer to extract the proteins.
2. Separation of proteins by electrophoresis: The extracted proteins are then separated based on their size by loading them onto a polyacrylamide gel and running an electric current through the gel (a process called sodium dodecyl sulfate-polyacrylamide gel electrophoresis or SDS-PAGE). This separates the proteins according to their molecular weight, with smaller proteins migrating faster than larger ones.
3. Transfer of proteins to a membrane: After separation, the proteins are transferred from the gel onto a nitrocellulose or polyvinylidene fluoride (PVDF) membrane using an electric current in a process called blotting. This creates a replica of the protein pattern on the gel but now immobilized on the membrane for further analysis.
4. Blocking: The membrane is then blocked with a blocking agent, such as non-fat dry milk or bovine serum albumin (BSA), to prevent non-specific binding of antibodies in subsequent steps.
5. Primary antibody incubation: A primary antibody that specifically recognizes the protein of interest is added and allowed to bind to its target protein on the membrane. This step may be performed at room temperature or 4°C overnight, depending on the antibody's properties.
6. Washing: The membrane is washed with a buffer to remove unbound primary antibodies.
7. Secondary antibody incubation: A secondary antibody that recognizes the primary antibody (often coupled to an enzyme or fluorophore) is added and allowed to bind to the primary antibody. This step may involve using a horseradish peroxidase (HRP)-conjugated or alkaline phosphatase (AP)-conjugated secondary antibody, depending on the detection method used later.
8. Washing: The membrane is washed again to remove unbound secondary antibodies.
9. Detection: A detection reagent is added to visualize the protein of interest by detecting the signal generated from the enzyme-conjugated or fluorophore-conjugated secondary antibody. This can be done using chemiluminescent, colorimetric, or fluorescent methods.
10. Analysis: The resulting image is analyzed to determine the presence and quantity of the protein of interest in the sample.

Western blotting is a powerful technique for identifying and quantifying specific proteins within complex mixtures. It can be used to study protein expression, post-translational modifications, protein-protein interactions, and more. However, it requires careful optimization and validation to ensure accurate and reproducible results.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Recombinant proteins are artificially created proteins produced through the use of recombinant DNA technology. This process involves combining DNA molecules from different sources to create a new set of genes that encode for a specific protein. The resulting recombinant protein can then be expressed, purified, and used for various applications in research, medicine, and industry.

Recombinant proteins are widely used in biomedical research to study protein function, structure, and interactions. They are also used in the development of diagnostic tests, vaccines, and therapeutic drugs. For example, recombinant insulin is a common treatment for diabetes, while recombinant human growth hormone is used to treat growth disorders.

The production of recombinant proteins typically involves the use of host cells, such as bacteria, yeast, or mammalian cells, which are engineered to express the desired protein. The host cells are transformed with a plasmid vector containing the gene of interest, along with regulatory elements that control its expression. Once the host cells are cultured and the protein is expressed, it can be purified using various chromatography techniques.

Overall, recombinant proteins have revolutionized many areas of biology and medicine, enabling researchers to study and manipulate proteins in ways that were previously impossible.

Enzyme activation refers to the process by which an enzyme becomes biologically active and capable of carrying out its specific chemical or biological reaction. This is often achieved through various post-translational modifications, such as proteolytic cleavage, phosphorylation, or addition of cofactors or prosthetic groups to the enzyme molecule. These modifications can change the conformation or structure of the enzyme, exposing or creating a binding site for the substrate and allowing the enzymatic reaction to occur.

For example, in the case of proteolytic cleavage, an inactive precursor enzyme, known as a zymogen, is cleaved into its active form by a specific protease. This is seen in enzymes such as trypsin and chymotrypsin, which are initially produced in the pancreas as inactive precursors called trypsinogen and chymotrypsinogen, respectively. Once they reach the small intestine, they are activated by enteropeptidase, a protease that cleaves a specific peptide bond, releasing the active enzyme.

Phosphorylation is another common mechanism of enzyme activation, where a phosphate group is added to a specific serine, threonine, or tyrosine residue on the enzyme by a protein kinase. This modification can alter the conformation of the enzyme and create a binding site for the substrate, allowing the enzymatic reaction to occur.

Enzyme activation is a crucial process in many biological pathways, as it allows for precise control over when and where specific reactions take place. It also provides a mechanism for regulating enzyme activity in response to various signals and stimuli, such as hormones, neurotransmitters, or changes in the intracellular environment.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Glycoproteins are complex proteins that contain oligosaccharide chains (glycans) covalently attached to their polypeptide backbone. These glycans are linked to the protein through asparagine residues (N-linked) or serine/threonine residues (O-linked). Glycoproteins play crucial roles in various biological processes, including cell recognition, cell-cell interactions, cell adhesion, and signal transduction. They are widely distributed in nature and can be found on the outer surface of cell membranes, in extracellular fluids, and as components of the extracellular matrix. The structure and composition of glycoproteins can vary significantly depending on their function and location within an organism.

Neoplasm invasiveness is a term used in pathology and oncology to describe the aggressive behavior of cancer cells as they invade surrounding tissues and organs. This process involves the loss of cell-to-cell adhesion, increased motility and migration, and the ability of cancer cells to degrade the extracellular matrix (ECM) through the production of enzymes such as matrix metalloproteinases (MMPs).

Invasive neoplasms are cancers that have spread beyond the original site where they first developed and have infiltrated adjacent tissues or structures. This is in contrast to non-invasive or in situ neoplasms, which are confined to the epithelial layer where they originated and have not yet invaded the underlying basement membrane.

The invasiveness of a neoplasm is an important prognostic factor in cancer diagnosis and treatment, as it can indicate the likelihood of metastasis and the potential effectiveness of various therapies. In general, more invasive cancers are associated with worse outcomes and require more aggressive treatment approaches.

'Tumor cells, cultured' refers to the process of removing cancerous cells from a tumor and growing them in controlled laboratory conditions. This is typically done by isolating the tumor cells from a patient's tissue sample, then placing them in a nutrient-rich environment that promotes their growth and multiplication.

The resulting cultured tumor cells can be used for various research purposes, including the study of cancer biology, drug development, and toxicity testing. They provide a valuable tool for researchers to better understand the behavior and characteristics of cancer cells outside of the human body, which can lead to the development of more effective cancer treatments.

It is important to note that cultured tumor cells may not always behave exactly the same way as they do in the human body, so findings from cell culture studies must be validated through further research, such as animal models or clinical trials.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

In humans, the gelatinases are matrix metalloproteinases MMP2 and MMP9. "Gelatinase". Medical Dictionary. Farlex and Partners. ... Gelatinases are enzymes capable of degrading gelatin. Gelatinases are expressed in several bacteria including Pseudomonas ...
BioAssay record AID 104720 submitted by ChEMBL: Inhibition of gelatinase-A (MMP-2).
Inhibition of human neutrophil gelatinase, matrix metalloprotease-2. ...
Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004;24: ... Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology 2010;15 ... Preoperative serum neutrophil gelatinase-associated lipocalin could be used on top of existing risk scores to further risk- ... Neutrophil gelatinase-associated lipocalin (NGAL) belongs to the lipocalin family and is produced predominantly by the liver ...
Background and aims To investigate the value of urinary neutrophil gelatinase associated lipocalin (NGAL) kidney injury ... PS-243 The Clinical Significance Of Urinary Neutrophil Gelatinase Associated Lipocalin, Kidney Injury Molecular-1 And ... PS-243 The Clinical Significance Of Urinary Neutrophil Gelatinase Associated Lipocalin, Kidney Injury Molecular-1 And ...
... , Bielefeld.. J. Fedrowitz, Isolierung und ... Isolierung und Charakterisierung von Gelatinase aus menschlichen Leukocyten. Fedrowitz J (1986) Bielefeld. ... Fedrowitz J. Isolierung und Charakterisierung von Gelatinase aus menschlichen Leukocyten. Bielefeld; 1986. ... Fedrowitz, J. (1986). Isolierung und Charakterisierung von Gelatinase aus menschlichen Leukocyten. Bielefeld. ...
Neutrophil Gelatinase-associated Lipocalin. In addition to its potential role in AKI diagnosis, NGAL may also be a useful ... Neutrophil Gelatinase-associated Lipocalin. NGAL is a 25-kD protein of the lipocalin family that is widely expressed and ... Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am ... Urinary neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury in sepsis patients in the emergency ...
... Neutrophil Gelatinase-Associated Lipocalin is a 25 kDa protein and as its ... name suggests, the protein in neutrophils is often found bound to gelatinase-B (also known as matrix metalloproteinase-9) ...
In Situ Gelatinase Zymography Gelatinase zymography is a relatively simple technique which utilizes enzymatic substrate-based ... The gelatinase hydrolyzes the gelatin in the gel and reveals the clear bands relative to metalloproteinases. The zymographic ... Gelatinase) expression in Brain tissue or in primary glial culture. Methods Mol. Biol. 2012, 814, 221-233. [Google Scholar] [ ... the proteins were clearly disclosed approximate to their molecular weights and the gelatinase zymograms were scanned using Las- ...
A class of MMPs is gelatinases which includes gelatinase A or MMP-2 (72 kDa) and gelatinase B or MMP-9 (92 kDa), which have ... A class of MMPs is gelatinases which includes gelatinase A or MMP-2 (72 kDa) and gelatinase B or MMP-9 (92 kDa), which have ... A still worthwhile method for gelatinases analysis in biological samples. Ricci, Serena;DEsposito, Vittoria;Oriente, Francesco ... A sensitive and unexpensive method for analysis of gelatinases is the gelatine zymography, which allows to measure the relative ...
Lipocalin-2/Neutrophil Gelatinase Associated-Lipocalin (NGAL). Product. Method / Application. Packaging. Use ?. Catalog #. ... Products ❳ Biomarkers ❳ Metabolic ❳ All Metabolic ❳ Lipocalin-2/Neutrophil Gelatinase Associated-Lipocalin (NGAL). ...
... the gelatinases are MMP2 (gelatinase A) and MMP9 (gelatinase B), as gelatin is a canonical substrate for these MMPs. ... Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different ... Gelatinases. Proteolytic enzymes that are capable of cleaving gelatin (denatured collagen). In the matrix metalloproteinase ( ...
Gelatinase activity was tested by spotting fresh cultures on nutrient gelatin agar plates. Strains were cultured at 37°C for 5 ... Hemolytic, Gelatinase, and General Enzymatic Activities. Hemolytic activity was determined by streaking the strains on Columbia ... None of the studied strains presented hemolytic or gelatinase activities (data not shown). API ZYM experiments revealed that ... and no strain displayed hemolytic or gelatinase activity nor produced biogenic amines, fulfilling safety prerequisites (Sanders ...
Raposo-Lima, C., Pereira, I.M., Marques, F. et al. Elevated levels of neutrophil gelatinase-associated lipocalin among OCD ... Elevated levels of neutrophil gelatinase-associated lipocalin among OCD patients: an exploratory study. ...
Neutrophil gelatinase-associated lipocalin (NGAL), cystatin C (Cys-C), and soluble triggering receptor expressed on myeloid ... From: Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on ... AKI, acute kidney injury; Cys-C, cystatin C; NGAL, neutrophil gelatinase-associated lipocalin; sTREM-1, soluble triggering ...
... and gelatinase(s), in skin, gingiva, and other tissues. A number of tetracyclines (TCs), both antimicrobial compounds as well ... and gelatinase(s), in skin, gingiva, and other tissues. A number of tetracyclines (TCs), both antimicrobial compounds as well ... TCs led to decreased weight loss and substantial reductions in the activity of both skin collagenase and skin gelatinase ( ...
... PubMed, SCI, Scopus ... CV: coefficient of variation, uNGAL: Urine neutrophil gelatinase-associated lipocalin, sNGAL: Serum neutrophil gelatinase- ... CV: coefficient of variation, uNGAL: Urine neutrophil gelatinase-associated lipocalin, sNGAL: Serum neutrophil gelatinase- ... CV: coefficient of variation, uNGAL: Urine neutrophil gelatinase-associated lipocalin, sNGAL: Serum neutrophil gelatinase- ...
... gelatinase; EF0818 and EF3023, hyaluronidase (spreading factor); sprE, serine protease; and fsr, quorum sensing system; toxin- ...
Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin instillation. Tomoko Betsuyaku, Yuh Fukuda ... Dive into the research topics of Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin ...
Diagnosis of Peripheral Artery Disease by Neutrophil Gelatinase-Associated lipocalin (NGAL), Ankle Brachial Index and Lipid ...
92 kDa gelatinase. 92-kDa type IV collagenase. GELB. MMP-9. gelatinase B. matrix metalloproteinase 9 (gelatinase B, 92-kDa type ... matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) *GenScript latest version of gene cDNA ...
Here, we describe fratricide as the governing principle behind gelatinase (GelE)-mediated cell death and eDNA release. GFP ... Here, we describe fratricide as the governing principle behind gelatinase (GelE)-mediated cell death and eDNA release. GFP ... reporter assays confirmed that GBAP (gelatinase biosynthesis-activating pheromone) quorum non-responders (GelE-SprE-) were a ...
Neutrophil gelatinase-associated lipocalin (NAGL): a novel biomarker for acute kidney injury].. ... Dive into the research topics of [Neutrophil gelatinase-associated lipocalin (NAGL): a novel biomarker for acute kidney injury ...
Lipocalin 2 (Lcn2) also called neutrophil gelatinase B-associated lipocalin (NGAL) is. Lipocalin 2 (Lcn2) also called ... neutrophil gelatinase B-associated lipocalin (NGAL) is an anti-microbial peptide originally identified in neutrophil granules. ...
Gelatinase. -. -. Indole production. -. -. Metabolic assay result. l. -arabinose. -. +. Malate. +. +. Citrate. +. +. Caprate. - ...
Urinary Neutrophil Gelatinase-Associated Lipocalin Can Predict the Efficacy of Volume Expansion Therapy in Patients With ... Table2_Urinary Neutrophil Gelatinase-Associated Lipocalin Can Predict the Efficacy of Volume Expansion Therapy in Patients With ... Table2_Urinary Neutrophil Gelatinase-Associated Lipocalin Can Predict the Efficacy of Volume Expansion Therapy in Patients With ... 13.8% p < 0.001). After logistic regression analysis, urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum ...
T1 - Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury ... Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury ... Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury ... title = "Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney ...
Urine neutrophil gelatinase associated lipocalin (NGAL) as a biomarker for acute canine kidney injury. BMC Vet Rec. 8: 248.. ... The Detection of Kidney Injury in Dogs by Biomarker: Neutrophil Gelatinase-Associated Lipocalin (NGAL) Article Sidebar. ... Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 71: 967-970.. Nabity ... Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury-where do we stand today? Nephrol. Dial. ...
... gelatinase-associated lipocalin (U-NGAL), U-NGAL/creatinine ratio, urine clusterin (U-clusterin) and U-clusterin/creatinine ... and urinary neutrophil gelatinase-associated lipocalin and clusterin. ...
  • Objective We aimed to investigate whether preoperative serum neutrophil gelatinase-associated lipocalin (sNGAL pre-op ) predicted postoperative acute kidney injury (AKI) during hospitalisation and 1-year cardiovascular and all-cause mortality following adult cardiac surgery. (bmj.com)
  • Background and aims To investigate the value of urinary neutrophil gelatinase associated lipocalin (NGAL) kidney injury molecular-1 (KIM-1) and interleukin-18 (IL-18) in the diagnosis of acute kidney injury (AKI) following childhood cardiopulmonary bypass (CPB). (bmj.com)
  • The search for early diagnostic methods revealed the Neutrophil gelatinase-associated lipocalin (NGAL) as a novel biomarker for detecting acute tubular injury (ATI). (fortuneonline.org)
  • On the other hand, the biomarker Neutrophil gelatinase-associated lipocalin (NGAL) can detect active tubular injury (ATI) from two hours after the start of the inducing event [1,2] which shows the precocity of NGAL in comparison to the traditional markers. (fortuneonline.org)
  • Neutrophil gelatinase-associated lipocalin (NAGL): a novel biomarker for acute kidney injury]. (biu.ac.il)
  • Dive into the research topics of '[Neutrophil gelatinase-associated lipocalin (NAGL): a novel biomarker for acute kidney injury]. (biu.ac.il)
  • Lipocalin 2 (Lcn2) also called neutrophil gelatinase B-associated lipocalin (NGAL) is an anti-microbial peptide originally identified in neutrophil granules. (healthandwellnesssource.org)
  • After logistic regression analysis, urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum creatinine (SCr) at diagnosis of AKI showed significant association with nonresponse to volume expansion therapy. (figshare.com)
  • Our aim was to study the predictive value of plasma neutrophil gelatinase-associated lipocalin (NGAL) at admission as a biomarker for AKI progression during the first 48 h of ICU admission in an unselected, heterogeneous ICU patient population. (hanze.nl)
  • The objective of this research was to investigate the application of Neutrophil Gelatinase-Associated Lipocalin (NGAL) canine biomarker, a protein that is increasing when renal tubular cells damage resulted for the acute kidney injury and kidney diseases in dogs. (tci-thaijo.org)
  • Serum and urine neutrophil gelatinase-associated lipocalin (NGAL) concentration in healthy dogs and dogs with chronic kidney disease. (tci-thaijo.org)
  • Review: neutrophil gelatinase-associated lipocalin: a troponin like biomarker for human acute kidney injury. (tci-thaijo.org)
  • Neutrophil Gelatinase-Associated Lipocalin in Dogs with Naturally Occurring Renal Diseases. (tci-thaijo.org)
  • The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. (tci-thaijo.org)
  • Neutrophil gelatinase-associated lipocalin, a sensitive urinary biomarker of acute kidney injury in dogs receiving gentamicin. (tci-thaijo.org)
  • Endotoxic kidney injury in Beagle dogs assessed by serum creatinine and symmetric dimethylarginine, and urinary neutrophil gelatinase-associated lipocalin and clusterin. (bvsalud.org)
  • At each timepoint, blood and urine were collected for serum creatinine , urea , symmetric dimethylarginine, urine protein / creatinine (UPC) ratio, urine neutrophil - gelatinase -associated lipocalin (U-NGAL), U-NGAL/ creatinine ratio, urine clusterin (U- clusterin ) and U- clusterin / creatinine ratio. (bvsalud.org)
  • Does Whole-Blood Neutrophil Gelatinase-Associated Lipocalin Stratify Acute Kidney Injury in Critically Ill Patients? (wustl.edu)
  • Neutrophil gelatinase-associated lipocalin (NGAL) is a secretory protein found in neutrophils, endothelial cells and in various organs of the gastrointestinal, respiratory, excretory and reproductive systems. (edu.pl)
  • Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., Barasch J., Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. (edu.pl)
  • Chakraborty S., Kaur S., Guha S., Batra S.K. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. (edu.pl)
  • Objective To evaluate renal tubular damage in dogs with stable MMVD by evaluation of urinary neutrophil gelatinase-associated lipocalin (NGAL). (unipr.it)
  • Buy Neutrophil Gelatinase Associated Lipocalin (NGAL) Detection Kit (Latex Enhanced Immunoturbidimetric Product on Nanjing Vazyme Biotech Co.,Ltd. (vazymemedical.com)
  • Neutrophil gelatinase associated lipocalin (NGAL) is an early and sensitive marker of acute kidney injury. (vazymemedical.com)
  • lcn2 is also known as 24p3 and neutrophil gelatinase-associated lipocalin (NGAL) ( Borregaard and Cowland, 2006 ). (jneurosci.org)
  • Methods and results: We measured estimated glomerular filtration rate (eGFR), urinary/serum neutrophil gelatinase-associated lipocalin (NGAL), and urinary albumin-to-creatinine ratio (u-ACR) in individuals with biopsy-proven. (lu.se)
  • Nevertheless, higher urine cadmium was inversely associated with estimated glomerular filtration rate (eGFR) (beta: -4.23, 95% confidence interval [CI]: -6.92, -1.54) and positively associated with neutrophil gelatinase-associated lipocalin (NGAL) (beta: 2.92, 95% CI: 1.20, 4.64). (cdc.gov)
  • GFP reporter assays confirmed that GBAP (gelatinase biosynthesis-activating pheromone) quorum non-responders (GelE-SprE-) were a minority subpopulation of prey cells susceptible to the targeted fratricidal action of the quorum responsive predatorial majority (GelE+SprE+). (nih.gov)
  • The introduction of a nonsense mutation into fsrB consistently impaired enterocin O16 production, but externally added gelatinase biosynthesis-activating pheromone restored the antimicrobial activity. (metu.edu.tr)
  • A class of MMPs is gelatinases which includes gelatinase A or MMP-2 (72 kDa) and gelatinase B or MMP-9 (92 kDa), which have been shown to play critical roles in pathophysiology of many human disease and, in particular, cancer progression. (uniroma1.it)
  • Diabetes mellitus in rats is characterized by excessive activity of several matrix metalloproteinases (MMPs), notably collagenase(s) and gelatinase(s), in skin, gingiva, and other tissues. (nih.gov)
  • By comparing the zymographic activity profiles of the gelatinases present in the samples obtained, it was deduced that the main source of these MMPs was granulocytes. (bmj.com)
  • They are classified into 5 groups according to substrate specificity and internal homology: collagenases, gelatinases, stromelysins, membrane-type MMPs, and others, including matrilysins 8 . (bvsalud.org)
  • In humans, the gelatinases are matrix metalloproteinases MMP2 and MMP9. (wikipedia.org)
  • Gelatinases are enzymes capable of degrading gelatin. (wikipedia.org)
  • A sensitive and unexpensive method for analysis of gelatinases is the gelatine zymography, which allows to measure the relative amounts of active and inactive enzymes in body fluids and tissue extracts. (uniroma1.it)
  • The gelatinases MMP-2 and MMP-9 are enzymes that will hydrolyse type IV collagen, the major component of basement membranes. (bmj.com)
  • Even though an improvement of this method is necessary for a better applicability in laboratory medicine, gelatine zymography represents the most convenient method to detect the activity of the different gelatinases from a wide range of biological samples. (uniroma1.it)
  • Protein kinase C-alpha activation by phorbol ester induces secretion of gelatinase B/MMP-9 through ERK 1/2 pathway in capillary endothelial cells. (ewha.ac.kr)
  • Dive into the research topics of 'Protein kinase C-alpha activation by phorbol ester induces secretion of gelatinase B/MMP-9 through ERK 1/2 pathway in capillary endothelial cells. (ewha.ac.kr)
  • In vivo, using rats made diabetic with streptozotocin (STZ), oral administration of various TCs led to decreased weight loss and substantial reductions in the activity of both skin collagenase and skin gelatinase (primarily MMP-9, 92 kDa) without affecting blood glucose. (nih.gov)
  • Here, we describe fratricide as the governing principle behind gelatinase (GelE)-mediated cell death and eDNA release. (nih.gov)
  • Human NGAL(Neutrophil Gelatinase Associated Lipocali. (istechk.com)
  • In humans, the gelatinases are matrix metalloproteinases MMP2 and MMP9. (wikipedia.org)
  • Gelatinases (MMP2 and MMP9) and their respective tissue inhibitors (TIMP1 and TIMP2) play a crucial role during extracellular matrix (ECM) turnover in aortic tissue. (nih.gov)
  • In this study we have investigated the effect of both pH (between pH 4.8 and 9.0) and temperature (between 15 degrees C and 37 degrees C) on the enzymatic functional properties of the neutrophil interstitial collagenase (MMP-8), gelatinases A (MMP-2) and B (MMP-9), using the same synthetic substrate, namely MCA-Pro-Leu-Gly approximate to Leu-DPA-Ala-Arg-NH2. (torvergata.it)
  • The functional behavior, although qualitatively similar, displays significant differences with respect to what was previously observed for stromelysin and porcine collagenase and gelatinase (Stack, M. S., and R. D. Gray. (torvergata.it)
  • The functional characterization of these enzymes can have some relevant physiological significance, since it may be related to the marked changes in the environmental pH that collagenase and gelatinases may experience in vivo, moving from the intracellular environment to the extracellular matrix. (torvergata.it)
  • A comparison between neutrophil collagenase and gelatinases A and B. BIOPHYSICAL JOURNAL, 79(4), 2138-2149. (torvergata.it)
  • Identification and evaluation of enzymes gelatinase, amylase, and catalase produced by rice root endophytic bacteria isolated from Hai Duong with antimicrobial properties against \(\textit{Xanthomonas oryzea}\) pv. (ac.vn)
  • In this study, we investigated the ability to produce exo/endo-enzymes such as gelatinase, amylase, and catalase, and antagonistic activity of 77 EB strains isolated from lowland rice roots grown in Doan Ket commune, Thanh Mien district, Hai Duong province, Vietnam. (ac.vn)
  • Aortas were assayed for transcriptional alterations of endothelin-1 ( ET-1 ), matrix metalloproteinase-9 ( MMP-9 ), tissue inhibitor of metalloproteinase-2 ( TIMP-2 ), and heme oxygenase-1 ( HO-1 ), along with measures of vascular lipid peroxides (LPOs) and gelatinase activity. (nih.gov)
  • In skin, MMP-2 (gelatinase A) and MMP-9 (gelatinase B) are normally inactive but can be expressed during tissue injury. (nih.gov)
  • The Weizmann Institute of Science team was looking to mimic the activity of the body's own tissue inhibitors of metalloproteinases (TIMPs) by generating molecules that would specifically inhibit MMP-9 (gelatinase) and the closely related MMP-2 (gelatinase A). (genengnews.com)
  • Small differences in the distribution of gene haplotypes could be associated with different levels of gene expression and in turn influence gelatinases activity in AAA. (nih.gov)
  • Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis. (cdc.gov)
  • In this study, prevalence of gelatinase and the effect of factors such as glucose concentration and pH have been investigated. (envirobiotechjournals.com)
  • Gelatinases are expressed in several bacteria including Pseudomonas aeruginosa and Serratia marcescens. (wikipedia.org)
  • This is the first investigation of this type on recombinant collagenases and gelatinases of human origin. (torvergata.it)
  • The molecule accumulated in focal inaflammatory-like patches, suggesting that metallobodies specifically target the activated form of the two gelatinases. (genengnews.com)
  • In this study we characterized associations between the haplotypes of genes encoding gelatinase/inhibitor pairs and pathways involved in AAA, a total of 100 AAA patients and 192 controls were enrolled. (nih.gov)

No images available that match "gelatinases"